Premium
First report of high levels of clindamycin‐resistant Propionibacterium acnes carrying erm (X) in Japanese patients with acne vulgaris
Author(s) -
NAKASE Keisuke,
NAKAMINAMI Hidemasa,
NOGUCHI Norihisa,
NISHIJIMA Setsuko,
SASATSU Masanori
Publication year - 2012
Publication title -
the journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.9
H-Index - 65
eISSN - 1346-8138
pISSN - 0385-2407
DOI - 10.1111/j.1346-8138.2011.01423.x
Subject(s) - pharmacy , pharmacy school , medicine , clindamycin , propionibacterium acnes , clinical microbiology , family medicine , microbiology and biotechnology , acne , pharmacy practice , dermatology , biology , antibiotics
tions in patients treated with ZD1839 (Iressa), an inhibitor of the epidermal growth factor receptor. Br J Dermatol 2002; 147: 598–601. 4 Agero AL, Dusza SW, Benvenuto-Andrade C et al. Dermatologic side effects associated with the epidermal growth factor receptor inhibitors. J Am Acad Dermatol 2006; 55: 657–670. 5 Katzer K, Tietze J, Klein E et al. Topical therapy with nadifloxacin cream and prednicarbate cream improves acneiform eruptions caused by the EGFR-inhibitor cetuximab – A report of 29 patients. Eur J Dermatol 2010; 20: 82–84. 6 Hachisuka J, Yunotani S, Shidahara S et al. Effect of adapalene on cetuximab-induced painful periungual inflammation. J Am Acad Dermatol 2011; 64: e20–e21. 7 DeWitt CA, Siroy AE, Stone SP. Acneiform eruptions associated with epidermal growth factor receptor-targeted chemotherapy. J Am Acad Dermatol 2007; 56: 500–505. 8 Njar VC, Gediya L, Purushottamachar P et al. Retinoids in clinical use. Med Chem 2006; 2: 431–438. 9 Shalita A, Weiss JS, Chalker DK et al. A comparison of the efficacy and safety of adapalene gel 0.1% and tretinoin gel 0.025% in the treatment of acne vulgaris: a multicenter trial. J Am Acad Dermatol 1996; 34: 482–485. 10 Pasonen-Seppanen SM, Maytin EV, Torronen KJ et al. All-trans retinoic acid-induced hyaluronan production and hyperplasia are partly mediated by EGFR signaling in epidermal keratinocytes. J Invest Dermatol 2008; 128: 797–807.